In The News
Class actions against Ford, Toyota score major win in High Court
Bid to revive Robodebt class action faces ‘significant hurdles’, says judge
Fearful of trolling, counsel tapped for Lehrmann wants to stay unnamed
In fight to protect UBank brand, NAB wins challenge to UWallet trade mark
Class closure ‘anathema’ to class action regime, contradictors tell High Court
Class action over COVID-19 deaths settles with Anglicare, NSW Health
MinRes boss Chris Ellison to step down after disclosure, integrity failures
Carnival settles class action over ‘cruise from hell’
Escala’s non-compete restraints against ex-partners an ‘overreach’: court
X appeals eSafety’s win over child exploitation notice
Please login to bookmarkClose

Generic drug maker Mayne Pharma Group has been hit with a shareholder class action over disclosures in relation to price-fixing allegations by US authorities.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au